PLATFORM

AxoSim's Nerve-on-a-Chip™ platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.

News

AxoSim receives NIH grant...

AxoSim, a startup that was spun out of Tulane University, has received a $1,770,000 grant over two years to advance their Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing. The grant...

Read Full Article

Axosim hiring scientists

Up-and-Coming AxoSim Hiring Scientists After Landing Research Grants to Speed Research. AxoSim, a biotech company headquartered in New Orleans, recently received two government grants totaling $455,000.

Read Full Article